查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014993

医疗植入市场：依产品类型、材料、技术和最终用户划分－2026-2032年全球市场预测

Medical Implants Market by Product Type, Material, Technology, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗植入市场价值将达到 1,235.6 亿美元，到 2026 年将成长至 1,335.1 亿美元，到 2032 年将达到 2,159.8 亿美元，复合年增长率为 8.30%。

主要市场统计数据
基准年 2025 1235.6亿美元
预计年份：2026年 1335.1亿美元
预测年份 2032 2159.8亿美元
复合年增长率 (%) 8.30%

对当前医疗植入市场趋势进行全面概述，重点关注产品、材料、技术和临床应用方面的创新。

目前医疗植入的发展现状，正处于生物医学工程进步、监管预期演变和临床路径演进的交汇点。器械设计、材料科学以及数位技术融合方面的创新，改变了临床医生和患者的期望，而采购趋势和医院基础设施也在持续影响植入物的实施方式。本文概述了涵盖循环系统、牙科、神经科、眼科和整形外科植入等领域的广泛当代活动，并阐述了产品层面的创新如何与材料选择和技术方法相结合，从而推动临床实践的变革。

对正在重塑植入设备的开发、引入和供应的变革性技术、材料和监管趋势进行权威性评述。

过去十年间，材料科学、微型化和数位化融合等多种因素的共同作用，为整个医疗植入领域带来了变革性的变化。积层製造和精密加工技术的进步，使得植入能够根据人体解剖结构进行定制，并为患者提供个人化解决方案，从而缩短手术时间并提高植入物的贴合度。同时，生物材料的改进，从用于牙科骨内植入的氧化锆陶瓷到用于脊柱和关节植入的PEEK和UHMWPE复合材料，都显着提升了长期植入的耐久性和生物相容性。此外，表面工程技术也取得了长足发展，例如抗菌涂层可以减少感染和炎症，以及药物释放曲线的控制。

对 2025 年美国关税调整如何影响植入相关人员的采购、采购做法和整体成本考量进行冷静分析。

2025年新关税政策的实施对医疗植入产业的采购、供应商策略和定价趋势产生了多方面的影响。关税调整影响了进口零件（包括精密金属、聚合物和成品）的成本结构，促使下游相关人员重新评估其采购、库存政策和供应商合约。许多原始设备製造商（OEM）的直接应对措施包括：与海外供应商重新谈判合约条款，尽可能提高国内采购比例，并加快认证替代供应商的流程，以降低单一来源依赖的风险。

横断面细分洞察，包括细微差别，追踪产品类型、先进材料、技术方法和最终用户如何相互作用，以确定临床采用和商业性机会。

从细分角度理解植入领域，可以揭示临床需求、材料特性和技术如何相互交织，从而创造差异化的机会。产品细分涵盖心血管植入物（包括心臟瓣膜、起搏器、裸金属或药物释放型支架以及可作为机械或组织型植入的血管移植物）、骨内、骨膜下和颧骨人工植牙（骨内解决方案进一步细分为钛或氧化锆材料）。神经系统植入包括胸腔内植入装置（包括内部和外部植入装置）、深部脑部刺激和脊髓刺激系统；眼科植入、青光眼引流装置和人工水晶体（设计类型包括景深扩展型、单焦点型、多焦点型和散光型）；以及整形外科植入（包括脊椎固定装置、运动医学系统和创伤关节，植入踝关节、髋关节、固定装置和固定装置。在基于材料的分类中，可选择的材料包括陶瓷、复合材料、金属和聚合物。钴铬合金、不銹钢和钛等金属因其独特的机械性能而被选中，而聚醚醚酮（PEEK）、硅胶和超高分子量聚乙烯（UHMWPE）等聚合物则因其耐磨性和生物相容性而被选中。在基于技术的细分中，主动植入（包括药物输送装置、深部脑部和脊髓亚型神经刺激设备以及感觉装置）与被动植入（包括固定装置和替换装置）相区别。在基于最终用户的细分中，识别出门诊手术中心、医院（分为医院附属机构和独立门诊机构，并进一步区分私立医院和公立医院）以及专科诊所，这些机构都会影响实施时间、采购标准和临床工作流程。

一项策略性区域分析揭示了全球各地法规、采购和临床偏好的差异如何影响商品化和供应的韧性。

区域趋势持续影响美洲、欧洲、中东和非洲以及亚太地区製造商、支付者和医疗服务提供者的战略重点。在美洲，如果创新医疗器材拥有可靠的临床证据和清晰的报销途径，则更倾向于快速引入。同时，采购量的增加以及医疗系统间的整合凸显了在整个生命週期中提供整合式服务和支援的重要性。在欧洲、中东和非洲，管理体制和采购模式各不相同，既有先进的集中式采购，也有分散的、因国而异的采购方式。在该地区运营的製造商需要根据各国不同的医疗技术评估流程调整其证据材料和定价策略。亚太地区的特点是既有对高端植入需求旺盛的成熟市场，也有新兴市场，在这些新兴市场中，价格可负担性、本地製造伙伴关係和规模是市场渗透的关键。

植入製造商展现出高度的企业策略和竞争行为，强调研发、伙伴关係、卓越製造和基于价值的商业化。

植入领域的主要企业正透过内部创新、有针对性的收购和策略联盟相结合的方式，拓展临床应用范围并强化产品系列。一些企业优先投入大规模进行研发，以提升材料科学、表面改质和设备小型化水平；而另一些企业则专注于平台多元化，将被动式替代设备与感测和自适应治疗等主动式数位功能相结合。与大学附属医院以及整形外科、循环系统和神经病学领域的意见领袖建立战略伙伴关係，在产生循证医学证据和迭代产品设计方面继续发挥着至关重要的作用。同时，製造商正投资于生产规模扩大、自动化和品管系统，以满足日益严格的监管要求，并建立能够处理植入植入物和患者客製化植入的灵活生产系统。

为领导者提供切实可行的建议，以协调产品设计、供应链弹性、证据生成和商业模式，从而确保竞争优势。

产业领导者应推动协调一致的策略，将产品开发、监管合规规划和商业性执行有机结合，以最大限度地满足临床需求，同时降低供应和政策风险。首先，优先考虑设计工厂製造 (DFM) 和模组化架构，以便在各个监管辖区实现快速迭代和便利检验。这种方法可以减少规模化生产的时间和成本，同时允许配置上的差异，例如材料选择和设备尺寸，以满足当地的临床偏好。其次，建构强大的供应商多元化和近岸製造方案，以降低关税波动和物流中断带来的风险，并辅以兼顾应对力和资本效率的策略性库存管理政策。第三，投资于产生能够同时展现传统疗效指标和以病人为中心的指标的临床证据。参与真实世界数据 (RWD) 计画和註册登记有助于增强临床医生和保险公司之间的信任。

对用于得出有关植入行业的策略见解的主要和次要调查方法、证据三角测量和检验程序进行透明的解释。

本分析的调查方法整合了多种资料收集和整合途径，以确保得出可靠且可重复的结论。主要研究包括对相关专科的临床医生、医院和门诊诊所的采购经理、监管专家以及供应链经理进行结构化访谈。这些访谈深入探讨了临床偏好、流程和采购标准，并提供了定性分析。次要研究则对同行评审文献、监管指导文件、生物相容性和无菌标准以及临床实践指南进行了系统性回顾，旨在将产品层面的评估和材料考量置于既定的临床和监管框架之内。

简洁的结论强调，整合创新、证据和供应韧性是整个植入生态系统长期成功的关键。

总之，医疗植入产业正进入一个以材料创新、尖端技术更紧密融合以及更加重视价值链韧性和价值主导采购为特征的阶段。产品差异化不仅日益依赖临床表现，还依赖材料选择、製造品质以及长期展现显着患者疗效的能力。法规和关税的变化促使企业推动本地化、供应商多元化并严格审查生命週期成本，迫使製造商和供应商重新思考其传统的商业模式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医疗植入市场：依产品类型划分

  • 心血管植入
    • 心臟瓣膜
      • 机器
      • 组织
    • 起搏器
    • 支架
      • 裸金属
      • 药物释放型型
    • 血管移植
  • 人工植牙
    • 骨内
      • 钛
      • 氧化锆
    • 骨膜下
    • 颧骨
  • 神经植入
    • 人工电子耳
      • 外部的
      • 内部的
    • 深部脑部刺激疗法
    • 脊髓刺激疗法
  • 眼科植入
    • 角膜植入
    • 青光眼引流装置
    • 人工水晶体
      • 扩展景深
      • 定焦镜头
      • 多焦点
      • 托里卡
  • 整形外科植入
    • 关节重建手术
      • 踝关节重建手术
      • 全髋关节置换术
      • 人工膝关节
      • 肩关节关节重建
    • 脊椎固定装置
    • 运动医学
    • 创伤固定装置

第九章 医疗植入市场：依材料分类

  • 陶瓷製品
  • 复合材料
  • 金属
    • 钴铬合金
    • 不銹钢
    • 钛
  • 聚合物
    • PEEK
    • 硅酮
    • UHMWPE

第十章 医疗植入市场：依技术划分

  • 主动植入
    • 药物输送装置
    • 神经刺激设备
      • 深部脑部刺激器
      • 脊髓刺激设备
    • 感测装置
  • 被动式植入
    • 固定装置
    • 替换装置

第十一章 医疗植入市场：依最终用户划分

  • 日间手术中心
    • 医院附属
    • 独立的
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所

第十二章 医疗植入市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 医疗植入市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 医疗植入市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国医疗植入市场

第十六章：中国医疗植入市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Edwards Lifesciences Corporation
  • GE HealthCare Technologies Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic plc
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0363DFE03666

The Medical Implants Market was valued at USD 123.56 billion in 2025 and is projected to grow to USD 133.51 billion in 2026, with a CAGR of 8.30%, reaching USD 215.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 123.56 billion
Estimated Year [2026] USD 133.51 billion
Forecast Year [2032] USD 215.98 billion
CAGR (%) 8.30%

A panoramic introduction to contemporary medical implant dynamics highlighting innovation across products, materials, technologies, and clinical adoption

The medical implants landscape sits at the intersection of advancing biomedical engineering, shifting regulatory expectations, and evolving clinical pathways. Innovation in device design, material science, and integration of digital technologies has transformed clinician and patient expectations, while procurement dynamics and hospital infrastructures continue to shape adoption. This introduction frames the breadth of contemporary activity across cardiovascular, dental, neurological, ophthalmic, and orthopedic implants, contextualizing how product-level innovation converges with material selection and technology modalities to drive clinical practice changes.

Understanding trajectories in implant design requires a cross-functional lens that includes surgeons, biomedical engineers, regulators, payers, and supply chain operators. Recent years have seen heightened scrutiny of long-term device performance, durability, and biocompatibility, which in turn has accelerated interest in advanced ceramics, high-performance polymers, and surface treatments that enhance osseointegration and reduce infection risk. Moreover, the integration of active technologies such as neurostimulators and drug delivery devices with passive replacement and fixation systems has introduced new regulatory and clinical pathways that demand coordinated evidence generation and post-market surveillance. Consequently, any executive assessment of the sector must balance clinical utility, material suitability, interoperability with digital health systems, and the implications of evolving procurement ecosystems.

An authoritative synthesis of the transformative technological, material and regulatory shifts reshaping how implantable devices are developed, adopted, and supplied

The past decade has produced transformative shifts across the medical implants landscape, driven by converging forces in materials science, miniaturization, and digital integration. Advances in additive manufacturing and precision machining have enabled anatomically tailored implants and patient-specific solutions, reducing intraoperative time and improving fit. At the same time, the refinement of biomaterials-ranging from ceramic zirconia for dental endosteal options to PEEK and UHMWPE composites in spinal and joint applications-has expanded the durability and biological compatibility of long-term implants. These material advances are complemented by surface engineering approaches that focus on antimicrobial coatings and modulated release profiles to mitigate infection and inflammation.

Concurrently, active implant technologies have matured; neurostimulation platforms for deep brain and spinal cord applications now incorporate closed-loop sensing and adaptive stimulation algorithms, and drug delivery implants leverage programmable release to achieve sustained therapeutic profiles. Regulatory regimes are adapting to these hybrid devices, requiring integrated clinical evidence that spans device performance, software reliability, and patient-reported outcomes. Supply chain resilience has become a strategic differentiator, prompting manufacturers to localize critical components and validate multi-sourcing strategies. Together, these shifts are redefining product development lifecycles, clinical decision-making, and competitive differentiation.

A clear-eyed analysis of how the 2025 United States tariff adjustments cascaded across sourcing, procurement practices, and total cost considerations for implant stakeholders

The introduction of new tariff policies in 2025 created layered effects across procurement, supplier strategy, and pricing dynamics within the medical implants sector. Tariff adjustments affected the cost structure for imported components, including precision metals, polymers, and finished devices, prompting downstream stakeholders to re-evaluate sourcing, inventory policies, and supplier contracts. For many original equipment manufacturers, the immediate response involved renegotiating terms with international suppliers, increasing emphasis on domestic content where feasible, and accelerating qualification of alternate vendors to mitigate single-source exposure.

Hospitals and ambulatory surgery centers reacted by intensifying value-based procurement practices, expanding bilateral discussions with suppliers to secure bundled pricing and extended warranty terms, and prioritizing devices with established supply resilience. Payers and health systems also showed greater interest in lifecycle cost analysis, weighing initial device cost against expected longevity, revision risk, and postoperative resource utilization. In parallel, regulatory and customs processes adapted to the new tariff landscape, generating additional compliance overhead for cross-border shipments. The cumulative outcome was a reorientation of commercial strategies toward regionalized supply chains, deeper supplier partnerships, and heightened scrutiny of total cost of ownership across implant categories.

A nuanced, cross-cutting segmentation insight tracing how product categories, advanced materials, technology modalities, and end users jointly determine clinical adoption and commercial opportunity

A segmentation-focused understanding of the implants space illuminates where clinical need, material performance, and technology converge to create differentiated opportunities. Product segmentation spans cardiovascular implants-comprising heart valves available as mechanical or tissue types, pacemakers, stents offered as bare metal or drug-eluting variants, and vascular grafts-through dental implants with endosteal, subperiosteal, and zygomatic forms where endosteal solutions are further defined by titanium or zirconia materials; neurological implants that include cochlear devices with internal and external configurations as well as deep brain and spinal cord stimulation systems; ophthalmic implants such as corneal implants, glaucoma drainage devices, and intraocular lenses that come in extended depth of focus, monofocal, multifocal, and toric designs; and orthopedic implants spanning joint replacement in ankle, hip, knee, and shoulder, as well as spinal fusion devices, sports medicine systems, and trauma fixation devices. Material segmentation reveals choices among ceramic, composite, metal, and polymer categories, with metals like cobalt chromium, stainless steel, and titanium selected for distinct mechanical profiles, and polymers including PEEK, silicone, and UHMWPE chosen for their wear characteristics and biocompatibility. Technology segmentation distinguishes active implants-encompassing drug delivery devices, neurostimulators with deep brain and spinal cord subtypes, and sensory devices-from passive implants that include fixation and replacement devices. End-user segmentation identifies ambulatory surgery centers, hospitals split into hospital-based and standalone ambulatory sites as well as private and public hospital distinctions, and specialty clinics, each influencing adoption timelines, purchasing criteria, and clinical workflows.

Examining these segments together highlights synergies and constraints: material advances like ceramic and high-performance polymers open new clinical applications for dental and spinal devices respectively, while active technologies drive the need for integrated care pathways that span outpatient and inpatient settings. End-user characteristics determine device preference and stocking strategies, with ambulatory centers often favoring minimally invasive and single-use technologies to optimize throughput, and hospitals prioritizing implants that demonstrate long-term durability and compatibility with existing surgical platforms. Strategic product development should therefore align device design to material advantages, regulatory requirements for active versus passive devices, and the procedural realities of the primary end users.

A strategic regional analysis revealing how differentiated regulatory, procurement, and clinical preferences across global regions influence commercialization and supply resilience

Regional dynamics continue to shape strategic priorities for manufacturers, payers, and providers in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific areas. In the Americas, clinical adoption tends to favor rapid integration of innovative devices when supported by robust clinical evidence and clear reimbursement pathways, while procurement volume and consolidation among health systems amplify the importance of integrated service offerings and total lifecycle support. Europe, Middle East & Africa presents a heterogeneous mix of regulatory regimes and procurement models, with pockets of advanced centralized purchasing coexisting alongside fragmented national approaches; manufacturers navigating this region must tailor evidence dossiers and pricing strategies to diverse national health technology assessment processes. Asia-Pacific is characterized by a mix of mature markets with high demand for premium implants and emerging markets where affordability, local manufacturing partnerships, and scale are key to gaining traction.

Across regions, cross-border regulatory harmonization efforts and mutual recognition agreements are influencing time to market, but regional supply chain resilience and localization remain practical imperatives. Providers in different geographies exhibit varied preferences for material types and device complexity based on procedural volumes and workforce capabilities. Thus, successful commercialization requires granular regional strategies that reconcile global product platforms with localized clinical evidence generation, reimbursement alignment, and supply chain planning.

High-level corporate strategies and competitive behaviors observed among implant manufacturers emphasizing R&D, partnerships, manufacturing excellence, and value-based commercialization

Leading companies in the implants arena are deploying a mix of organic innovation, targeted acquisitions, and strategic partnerships to expand clinical reach and strengthen product portfolios. Some firms prioritize deep investments in R&D to enhance material science, surface modification, and device miniaturization, while others focus on platform diversification to combine passive replacement devices with active digital capabilities such as sensing and adaptive therapy. Strategic alliances with academic medical centers and orthopaedic, cardiovascular, and neurological thought leaders continue to be instrumental for evidence generation and iterative product design. In parallel, manufacturers are investing in manufacturing scale-up, automation, and quality management systems to meet tightening regulatory expectations and to enable flexible production for both standard and patient-specific implants.

Commercially, leading players concentrate on value-based selling models that emphasize total cost of care, patient outcomes, and service commitments, including instrument maintenance, training, and data-driven follow-up. They also prioritize supply chain transparency and supplier qualification programs to reduce risk associated with single-source components. Firms with strong portfolios in metals and polymers are exploring cross-application opportunities, bringing materials expertise from orthopaedics into spinal and dental solutions, while companies with capabilities in active technologies are integrating software and connectivity to create differentiated therapy ecosystems. Together, these strategic moves indicate a landscape where competitive advantage accrues to organizations that can combine technical excellence, regulatory savvy, and partner-centric commercialization models.

Practical, high-impact recommendations for leaders to align product design, supply resilience, evidence generation, and commercial models to secure competitive advantage

Industry leaders should pursue a coordinated set of actions that align product development, regulatory planning, and commercial execution to capitalize on clinical demand while mitigating supply and policy risks. First, prioritize design-for-manufacturing and modular architectures that enable faster iteration and easier validation across regulatory jurisdictions. This approach reduces time and cost during scale-up while allowing for configuration variants such as material choices or device sizes that meet regional clinical preferences. Second, build robust supplier diversification and near-shore manufacturing options to reduce exposure to tariff volatility and logistics disruptions, complemented by strategic inventory policies that balance responsiveness with capital efficiency. Third, invest in clinical evidence generation that speaks to both traditional outcomes and patient-centric metrics; real-world data programs and registry participation can accelerate trust among clinicians and payers.

Fourth, adopt commercial models that foreground outcome-based contracting and bundled-service offerings to differentiate in procurement discussions, and ensure sales teams are equipped to articulate total cost of care narratives. Fifth, for companies working with active devices, harmonize software development lifecycles with medical device quality systems, and plan for cybersecurity, interoperability, and post-market performance monitoring. Finally, cultivate partnerships with healthcare systems and specialized clinics to co-develop care pathways that optimize device utilization and demonstrate value across settings. Taken together, these recommendations are actionable and focused on building resilient, evidence-driven businesses capable of navigating regulatory, commercial, and supply-side complexity.

A transparent explanation of primary and secondary research methods, evidence triangulation, and validation steps used to produce the strategic implant industry insights

The research methodology underpinning this analysis integrated multiple data collection and synthesis approaches to ensure robust, reproducible insight. Primary research included structured interviews with clinicians across relevant specialties, procurement leaders from hospitals and ambulatory care settings, regulatory experts, and supply chain managers. These conversations provided qualitative depth on clinical preferences, procedural workflows, and purchasing criteria. Secondary research involved systematic review of peer-reviewed literature, regulatory guidance documents, standards for biocompatibility and sterilization, and clinical practice guidelines to ground product-level assessments and material considerations in accepted clinical and regulatory frameworks.

Analytical methods combined thematic coding of interview data, comparative analysis of device attributes across product, material, and technology dimensions, and scenario mapping to explore the implications of tariff and supply-chain shifts. Validation exercises included peer review with external clinical advisors and cross-checking of technical assertions against regulatory documents and published clinical evidence. The methodology emphasized transparency in source attribution and conservative interpretation of observed trends, ensuring that strategic recommendations are actionable and supported by multiple lines of evidence.

A concise concluding perspective emphasizing how integrated innovation, evidence, and supply resilience will determine long-term success across the implants ecosystem

In conclusion, the medical implants sector is entering a phase defined by material innovation, tighter integration of active technologies, and an intensified focus on supply-chain resilience and value-driven procurement. Product differentiation increasingly depends not only on clinical performance but also on material selection, manufacturing quality, and the ability to demonstrate meaningful patient outcomes over the long term. Regulatory and tariff shifts have created urgency around localization, supplier diversification, and lifecycle cost scrutiny, prompting manufacturers and providers to rethink standard operating models.

Looking ahead, organizations that align R&D investments with pragmatic manufacturing strategies, that strengthen partnerships with clinical leaders and health systems, and that deploy evidence generation programs emphasizing real-world outcomes will be best positioned to capture clinical trust and commercial traction. Cross-functional coordination among product developers, regulatory affairs, supply chain, and commercial teams will be essential to navigate complexity and convert technological promise into sustained clinical impact and operational success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Implants Market, by Product Type

  • 8.1. Cardiovascular Implants
    • 8.1.1. Heart Valves
      • 8.1.1.1. Mechanical
      • 8.1.1.2. Tissue
    • 8.1.2. Pacemakers
    • 8.1.3. Stents
      • 8.1.3.1. Bare Metal
      • 8.1.3.2. Drug Eluting
    • 8.1.4. Vascular Grafts
  • 8.2. Dental Implants
    • 8.2.1. Endosteal
      • 8.2.1.1. Titanium
      • 8.2.1.2. Zirconia
    • 8.2.2. Subperiosteal
    • 8.2.3. Zygomatic
  • 8.3. Neurological Implants
    • 8.3.1. Cochlear
      • 8.3.1.1. External
      • 8.3.1.2. Internal
    • 8.3.2. Deep Brain Stimulation
    • 8.3.3. Spinal Cord Stimulation
  • 8.4. Ophthalmic Implants
    • 8.4.1. Corneal Implants
    • 8.4.2. Glaucoma Drainage Devices
    • 8.4.3. Intraocular Lenses
      • 8.4.3.1. Extended Depth Of Focus
      • 8.4.3.2. Monofocal
      • 8.4.3.3. Multifocal
      • 8.4.3.4. Toric
  • 8.5. Orthopedic Implants
    • 8.5.1. Joint Replacement
      • 8.5.1.1. Ankle Replacement
      • 8.5.1.2. Hip Replacement
      • 8.5.1.3. Knee Replacement
      • 8.5.1.4. Shoulder Replacement
    • 8.5.2. Spinal Fusion Devices
    • 8.5.3. Sports Medicine
    • 8.5.4. Trauma Fixation Devices

9. Medical Implants Market, by Material

  • 9.1. Ceramic
  • 9.2. Composite
  • 9.3. Metal
    • 9.3.1. Cobalt Chromium
    • 9.3.2. Stainless Steel
    • 9.3.3. Titanium
  • 9.4. Polymer
    • 9.4.1. PEEK
    • 9.4.2. Silicone
    • 9.4.3. UHMWPE

10. Medical Implants Market, by Technology

  • 10.1. Active Implants
    • 10.1.1. Drug Delivery Devices
    • 10.1.2. Neurostimulator
      • 10.1.2.1. Deep Brain Stimulator
      • 10.1.2.2. Spinal Cord Stimulator
    • 10.1.3. Sensory Devices
  • 10.2. Passive Implants
    • 10.2.1. Fixation Devices
    • 10.2.2. Replacement Devices

11. Medical Implants Market, by End User

  • 11.1. Ambulatory Surgery Centers
    • 11.1.1. Hospital Based
    • 11.1.2. Standalone
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals
  • 11.3. Specialty Clinics

12. Medical Implants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Implants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Implants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Implants Market

16. China Medical Implants Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Baxter International Inc.
  • 17.7. Becton, Dickinson and Company
  • 17.8. Boston Scientific Corporation
  • 17.9. Cardinal Health, Inc.
  • 17.10. Edwards Lifesciences Corporation
  • 17.11. GE HealthCare Technologies Inc.
  • 17.12. Intuitive Surgical, Inc.
  • 17.13. Johnson & Johnson
  • 17.14. Koninklijke Philips N.V.
  • 17.15. Medtronic plc
  • 17.16. Siemens Healthineers AG
  • 17.17. Smith & Nephew plc
  • 17.18. Stryker Corporation
  • 17.19. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SUBPERIOSTEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SUBPERIOSTEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SUBPERIOSTEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ZYGOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ZYGOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ZYGOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY EXTERNAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY INTERNAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY INTERNAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY INTERNAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CORNEAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CORNEAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CORNEAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY EXTENDED DEPTH OF FOCUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY EXTENDED DEPTH OF FOCUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY EXTENDED DEPTH OF FOCUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MONOFOCAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MONOFOCAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MONOFOCAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MULTIFOCAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MULTIFOCAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MULTIFOCAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TORIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TORIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TORIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ANKLE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ANKLE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ANKLE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SHOULDER REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SHOULDER REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SHOULDER REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL FUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TRAUMA FIXATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CERAMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PEEK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PEEK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PEEK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY UHMWPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY UHMWPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY UHMWPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SENSORY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SENSORY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SENSORY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY REPLACEMENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY REPLACEMENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY REPLACEMENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HOSPITAL BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HOSPITAL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 235. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, 2018-2032 (USD MILLION)
  • TABLE 236. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 237. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 239. AMERICAS MEDICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 260. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 262. NORTH AMERICA MEDICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, 2018-2032 (USD MILLION)
  • TABLE 282. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA MEDICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY COCHLEAR, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 326. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY ACTIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 327. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATOR, 2018-2032 (USD MILLION)
  • TABLE 328. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY PASSIVE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 329. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. EUROPE MEDICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGERY